Skip to content

Cost-effectiveness of a stepped care strategy to improve symptoms of depression or anxiety in patients treated for head and neck cancer or lung cancer.

Cost-effectiveness of a stepped care strategy to improve symptoms of depression or anxiety in patients treated for head and neck cancer or lung cancer. - STEP-study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39087
Enrollment
152
Registered
2009-08-20
Start date
2009-12-12
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychische stoornissen: angststoornissen en -symptomen anxiety and depression

Interventions

Stepped care model with 4 evidence based steps: 1. Watchful waiting, 2. Internet-based self-help, 3. Problem Solving Therapy applied by a nurse, and 4. Specialised psychological interventions and/or

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Treatment for UICC stage I-IV lung or head and neck carcinoma: ICD-10 C00-C14 (lip, oral cavity and pharynx), C32 (larynx), C33 (trachea), C34 (lung); psychological distress or possible or probable cases of depression or anxiety as assessed by the Hospital Anxiety Depression Scale (HADS-Anxiety subscale score > 7 and/or HADS-Depression subscale score > 7, or total score on HADS > 14). For more details, see page 11 of the researchprotocol.

Exclusion criteria

Exclusion criteria: Other (neurological) diseases causing cognitive dysfunction; no motivation to undergo psychosocial therapy; current treatment for a depressive or anxiety disorder; end of treatment for a psychiatric disorder less than two months ago, high suicide risk; psychotic and/or manic signs; too little knowledge of the Dutch language to fill out the questionnaires.

Design outcomes

Primary

MeasureTime frame
Primary outcome is the Hospital Anxiety and Depression Scale (HADS) and costs (health care utilization and work loss (TIC-P and PRODISQ modules)).

Secondary

MeasureTime frame
Secondary outcome measures are quality of life questionnaires (EORTC QLQ-C30, EORTC QLQ-HN35, EORTC QLQ-LC13) and patient satisfaction with care (EORTC QLQ-PATSAT).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)